Bionano Genomics Inc (BNGO)
0.7576
-0.05
(-5.86%)
USD |
NASDAQ |
Jun 21, 16:00
0.751
-0.01
(-0.87%)
Pre-Market: 08:16
Bionano Genomics Research and Development Expense (TTM): 49.88M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 49.88M |
December 31, 2023 | 54.03M |
September 30, 2023 | 56.34M |
June 30, 2023 | 55.30M |
March 31, 2023 | 52.46M |
December 31, 2022 | 49.05M |
September 30, 2022 | 44.25M |
June 30, 2022 | 38.01M |
March 31, 2022 | 30.33M |
December 31, 2021 | 22.48M |
September 30, 2021 | 16.15M |
June 30, 2021 | 11.94M |
March 31, 2021 | 10.26M |
Date | Value |
---|---|
December 31, 2020 | 10.26M |
September 30, 2020 | 9.778M |
June 30, 2020 | 9.648M |
March 31, 2020 | 9.655M |
December 31, 2019 | 9.081M |
September 30, 2019 | 9.204M |
June 30, 2019 | 9.535M |
March 31, 2019 | 9.225M |
December 31, 2018 | 9.492M |
September 30, 2018 | 9.428M |
June 30, 2018 | 9.890M |
March 31, 2018 | 11.19M |
December 31, 2017 | 12.01M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
9.081M
Minimum
Dec 2019
56.34M
Maximum
Sep 2023
27.88M
Average
19.32M
Median
Research and Development Expense (TTM) Benchmarks
Revvity Inc | 210.25M |
Bruker Corp | 307.60M |
Azenta Inc | 35.10M |
Harvard Bioscience Inc | 11.75M |
Akoya Biosciences Inc | 21.67M |